
Methylphenidate ER (cd) Coupons & Savings Card – Discount Prices from $42.18
Generic for: Metadate cd
My prescription
Edit
10MG, Methylphenidate ER (cd) (30 Capsule Extended Releases)
Select pharmacy

CVS
$42.18
COUPON PRICE
Albertsons
$48.39
COUPON PRICE
Walgreens
$51.30
COUPON PRICEMethylphenidate ER (cd) savings card
Show this card to your pharmacist
CVS
$42.18
BIN
ID
PCN
GRP
019876
LH8E1FD989
CHIPPO
LHX
Powered by
More prescriptions for adhd
More prescriptions for adhd
Price history for Metadate Cd (brand) & Methylphenidate ER (cd) (generic)
30 Capsule Extended Releases, 10MG
Average retail price for Metadate Cd
Average retail price for Methylphenidate ER (cd)
Average SaveHealth price for Methylphenidate ER (cd)
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
We analyzed Methylphenidate ER (cd) prices for (10MG, 30 Capsule Extended Releases) over the last 12 months. The average retail price was $208.88, while the average price using the SaveHealth discount card was $55.69. That's a savings of approximately 73.34% when using our Methylphenidate ER (cd) coupon.
Compared to the generic version, Metadate Cd had an average price of $716.24 over the same time period. With the SaveHealth savings card, Methylphenidate ER (cd) is 92.22% cheaper on average than Metadate Cd.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Methylphenidate ER (cd) dosage forms
Dosage | Quantity | Price from | Per unit |
---|---|---|---|
10MG | 30 Capsule Extended Releases | $42.18 | $1.41 |
20MG | 30 Capsule Extended Releases | $32.64 | $1.09 |
30MG | 30 Capsule Extended Releases | $42.18 | $1.41 |
40MG | 30 Capsule Extended Releases | $42.18 | $1.41 |
50MG | 30 Capsule Extended Releases | $42.18 | $1.41 |
60MG | 30 Capsule Extended Releases | $52.83 | $1.76 |
Methylphenidate ER (cd) Warnings
When considering the use of methylphenidate extended-release capsules (CD), it's important to be aware of several potential risks:
Cardiovascular Concerns: This medication can lead to increased blood pressure and heart rate. Individuals with existing heart conditions, such as structural abnormalities, cardiomyopathy, serious arrhythmias, or coronary artery disease, may face heightened risks, including sudden death. Therefore, it's crucial to inform your healthcare provider about any personal or family history of heart problems before starting treatment.
Psychiatric Effects: Methylphenidate may exacerbate symptoms in individuals with pre-existing psychotic disorders. It can also trigger manic episodes in those with bipolar disorder. Additionally, new psychotic or manic symptoms, such as hallucinations or delusional thinking, have been reported in patients without prior history of these conditions. If you experience any unusual changes in mood or behavior, contact your healthcare provider promptly.
Growth Suppression in Children: Long-term use of methylphenidate in children has been associated with a temporary slowing of growth rate, resulting in less growth in height and weight over a period of years. Regular monitoring of a child's growth is recommended during treatment.
Seizure Risk: There is evidence that stimulants like methylphenidate may lower the seizure threshold, potentially increasing the risk of seizures, especially in individuals with a history of seizures or EEG abnormalities. If seizures occur, discontinuation of the medication should be considered.
Priapism: Prolonged and painful erections, known as priapism, have been reported with methylphenidate use in both pediatric and adult patients. This condition can develop after some time on the medication, often following an increase in dose, or during periods of drug withdrawal. Immediate medical attention is necessary if this occurs.
Peripheral Vasculopathy, Including Raynaud's Phenomenon: Use of methylphenidate has been associated with circulation problems in fingers and toes, leading to symptoms like numbness, coolness, pain, or color changes. In rare cases, this can result in digital ulceration or soft tissue breakdown. Monitoring for these signs is important during treatment.
Visual Disturbances: Difficulties with accommodation and blurred vision have been reported with stimulant treatment. If you experience any changes in vision, consult your healthcare provider.
Use in Young Children: The safety and efficacy of methylphenidate extended-release capsules (CD) have not been established in children under six years of age. Therefore, it is not recommended for use in this age group.
Drug Dependence: Methylphenidate has a high potential for abuse and dependence. Chronic abusive use can lead to marked tolerance and psychological dependence, with varying degrees of abnormal behavior. Careful supervision is required during withdrawal from abusive use, as severe depression may occur.
Before starting methylphenidate extended-release capsules (CD), discuss these potential risks with your healthcare provider to determine if this medication is appropriate for you.
Methylphenidate ER (cd) Side Effects
Methylphenidate extended-release capsules (CD) are commonly prescribed to manage attention deficit hyperactivity disorder (ADHD). While effective, they can cause various side effects, ranging from mild to serious. It's important for patients and caregivers to be aware of these potential reactions. Common Side Effects:
- Appetite Suppression: Many individuals experience a decreased appetite, which can lead to weight loss over time.
- Insomnia: Difficulty falling or staying asleep is frequently reported.
- Headaches and Stomachaches: Some users may encounter headaches or abdominal discomfort.
- Nervousness and Dizziness: Feelings of nervousness or dizziness can occur, especially when starting the medication. Serious Side Effects:
- Cardiovascular Issues: The medication can increase heart rate and blood pressure. In rare cases, it has been associated with serious heart problems, including sudden death in individuals with pre-existing heart conditions.
- Mental Health Changes: Some patients may experience new or worsening psychiatric symptoms, such as aggression, hostility, or manic episodes.
- Circulation Problems: Methylphenidate can cause issues like Raynaud's phenomenon, where fingers or toes feel numb, cool, or painful and may change color.
- Prolonged Erections (Priapism): Although rare, prolonged and painful erections have been reported and require immediate medical attention.
- Growth Suppression in Children: Long-term use may slow growth in children; regular monitoring of height and weight is recommended. Other Considerations:
- Seizures: There's evidence that stimulants may lower the seizure threshold, particularly in individuals with a history of seizures.
- Visual Disturbances: Blurred vision or difficulties with visual accommodation have been reported.
- Dependency and Abuse Potential: Methylphenidate has a high potential for abuse and dependence. Misuse can lead to serious health risks, including addiction. Patients should discuss any concerns or side effects with their healthcare provider to ensure safe and effective use of methylphenidate extended-release capsules.
Methylphenidate ER (cd) Interactions
When taking methylphenidate extended-release capsules (CD), it's important to be aware of potential interactions with other substances:
Monoamine Oxidase Inhibitors (MAOIs): Combining methylphenidate with MAOIs can lead to a dangerous increase in blood pressure, potentially causing severe health issues. Avoid using methylphenidate if you're currently taking MAOIs or have stopped taking them within the past 14 days.
Antihypertensive Medications: Methylphenidate may reduce the effectiveness of blood pressure-lowering drugs. Regular monitoring of your blood pressure is advisable, and adjustments to your antihypertensive medication may be necessary.
Alcohol: Consuming alcohol while on methylphenidate can accelerate the release of the medication into your system, increasing the risk of side effects. It's best to avoid alcohol during treatment.
Caffeine: Both caffeine and methylphenidate stimulate the central nervous system. Excessive caffeine intake can heighten side effects like nervousness, insomnia, and rapid heartbeat. Limit your consumption of caffeine-containing foods and beverages, such as coffee, tea, colas, and chocolate.
Certain Antidepressants and Anticonvulsants: Methylphenidate may interfere with the metabolism of some antidepressants (like tricyclics and SSRIs) and anticonvulsants (such as Phenobarbital and Phenytoin), potentially leading to increased levels of these drugs in your body. Your doctor may need to adjust dosages and monitor drug levels if you're taking these medications concurrently.
Risperidone: Using methylphenidate alongside risperidone, especially when changing the dose of either medication, may raise the risk of movement disorders known as extrapyramidal symptoms. Be vigilant for any unusual movements or muscle stiffness and inform your healthcare provider promptly.
Always inform your doctor about all medications, supplements, and over-the-counter products you're using to ensure safe and effective treatment with methylphenidate.
Is methylphenidate CD still available?
Yes, methylphenidate CD is still available. It is a medication commonly used to treat attention deficit hyperactivity disorder (ADHD).
Is methylphenidate CD like Adderall?
Methylphenidate CD and Adderall are both medications used to treat attention deficit hyperactivity disorder (ADHD), but they contain different active ingredients. Methylphenidate CD contains methylphenidate, while Adderall contains a combination of amphetamine salts. Both medications are central nervous system stimulants and work by affecting certain chemicals in the brain to help improve attention and focus. However, they have different formulations and may have different effects and side effects for individuals. It is important for a healthcare provider to determine which medication is most appropriate for a patient.
How similar is methylphenidate to Adderall?
Methylphenidate and Adderall are both central nervous system stimulants used to treat attention deficit hyperactivity disorder (ADHD). However, they differ in their chemical composition and mechanism of action. Methylphenidate primarily affects the reuptake of dopamine and norepinephrine, while Adderall, which contains amphetamine salts, increases the release of these neurotransmitters. Despite these differences, both medications aim to improve focus and reduce impulsivity and hyperactivity in individuals with ADHD. The choice between them often depends on individual response and side effect profiles.
Is methylphenidate CD being discontinued?
As of the latest available information, there is no indication that methylphenidate CD is being discontinued. It is always advisable to check with a healthcare provider or pharmacist for the most current information regarding medication availability.
What is methylphenidate CD generic for?
Methylphenidate CD is the generic form of the brand-name medication Metadate CD.